|
⚲
|
| Keyboard |
| Zuo William Wei
✚
|
|
|---|---|
| CIK # | 0001427110 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001427110] | |
| 4 | [0001427110] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zuo William Wei | |
| Kinex Pharmaceuticals LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Unit · derivative
|
2021-08-03 | Grant | 12,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2021-08-03 | Grant | 12,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-03-04 | Sell | 419,931 | $4.52 | 1,898,088 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2020-06-11 | Other | 559,389 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2020-06-05 | Grant | 25,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2019-04-16 | Grant | 3,426 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2019-03-25 | Buy | 1,000 | $12.47 | 12,470 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-02-28 | Grant | 25,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2018-03-27 | Grant | 25,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2017-06-19 | Grant | 1 | $0.00 |